Hyperglycemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells

Diabetes

Volumn 48, Issue 4, 1999, Pages 855-864

  Yerneni, Kiran Kumar V ^a   Bai, Wei ^a   Khan, Bobby V ^b   Medford, Russell M ^b   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; SUPEROXIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; DIABETIC ANGIOPATHY; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0033037930     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.4.855     Document Type: Article

References (47)

1. Thanos D, Maniatis T: NF-KB: a lesson in family values. Cell 80:529-532, 1995
2. Baeuerle PA, Baltimore D: IKB: a specific inhibitor of the NK-KB transcription factor. Science 242:540-546, 1988
3. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-KB transcription factor and HIV-1. EMBO J 10:2247-2258, 1991
4. Baeuerle PA: The inducible transcription factor NF-KB: regulation by distinct protein subunits. Biochim Biophys Acta 1072:63-80, 1991
5. Lenardo MJ, Baltimore D: NF-KB: a pleiotropic medial or of inducible and tissue-specific gene control. Cell 58:227-229, 1989
6. Berliner JA, Territo M, Andalibi A, Navab M, Liao F, Cushing S, Imes S, Kim J, van Lenten B, Lusis AJ, Fogleman AM: Modified lipoproteins and atherogenesis. In Cellular and Molecular Biology of Atherosclerosis. Gotto JAM, Ed. London, Springer-Verlag, 1992, p. 77-80
7. Liao F, Andalibi A, DeBeer FC, Fogelman AM, Lusis AJ: Genetic control of inflammatory gene induction and NF-KB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:2572-2579, 1993
8. Collins T: Endothelial nuclear factor-KB and the initiation of the atherosclerotic lesion. Lab Invest 68:499-508, 1993
9. Brand K, Page H, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D: Activated transcription factor nuclear factor-KB is present in the atherosclerotic lesion. J Clin Invest 97:1715-1722, 1996
10. Baeuerle PA, Henkel T: Function and activation of NF-KB in immune system. Ann Rev Immunol 12:141-1711, 1994
11. Hiscott J, Marois J, Garocifalis J, Addarion MD, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, Fenton M: Characterization of a functional NK-KB site in the human interleukin-1β promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 13:6231-6240, 1993
12. Cybulsky MI, Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791, 1991
13. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC: Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 207:1632-16329, 1992
14. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaque. Am J Pathol 140:665-673, 1992
15. Ruderman NB, Williamson JR, Brownlee M: Glucose and diabetic vascular disease. FASEB J 6:2905-2914, 1992
16. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
17. Vlassara H: Advanced glycation end products and atherosclerosis. Ann Med 28:419-426, 1996
18. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1320, 1988
19. Schmidt AM, Hori O, Brett J, Van SD, Wautier J-L, Stern D: Cellular receptors for advanced glycosylation end products: implication for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14:1521-1528, 1994
20. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang Z, Cao R, Yan SD, Brett J, Stern D: Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 96:1395-1403, 1995
21. Natarajan R, Gonzales N, Xu L, Nadler J: Vascular smooth muscle cells exhibit increased growth response to elevated glucose. Biochem Biophys Res Comnum 87:552-560, 1992
22. Natarajan R, Gonzales N, Lanting L, Nadler J: Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy. Hypertension 23:I142-I147, 1994
23. Natarajan R, Bai W, Rangarajan V., Gonzales N, Gu J-L, Linda L, Nadler JL: Platelet-derived growth factor-BB-mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells. J Cell Physiol 169:391-400, 1996
24. Lawrence R, Chang L-J, Siebenlist U, Bressler P, Sonenshein G: Vascular smooth muscle cells express a constitutive NF-KB-like activity. J Biol Chem 269:28913-28918, 1994
25. Bellas RE, Lee JS, Sonenshein G: Expression of a constitutive NF-KB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest 96:2521-2527, 1995
26. Bourcier T, Sukhova G, Libby P: The nuclear factor KB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 272:15817-15824, 1997
27. Natarajan R, Gu J-L, Rossi J, Gonzales N, Lanting L, Xu L, Nadler J: Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci U S A 90: 4947-4951, 1993
28. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM: Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human endothelial cells. J Clin Invest 92:1866-1874, 1993
29. Khan BVK, Harrison DG, Olbrych MT, Alexander RW, Medford RM: Nitric oxide regulates vascular cell adhesion molecule gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A 93:9114-9119, 1996
30. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, Struhl K: In Current Protocols in Molecular Biology. New York, Wiley, 1991
31. Titus DE: Promega Protocols and Applications Guide, 2nd ed. Madison, WI, Promega, 1991, p. 285-296
32. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148, 1994
33. Autieri MV, Yue TL, Ferstein GZ, Ohlstein E: Antisense oligonucleutides to the p65 subunit of NF-KB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neiointima formation in rat carotid arteries. Biochem Biophys Res Commun 213:827-826, 1995
34. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T: Functional analysis of the human vascular cell adhesion molecule-1 promoter. J Exp Med 176:1583-1593, 1992
35. Kim JA, Berliner, JA, Natarajan B, Nadler JL: Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43:1103-1107, 1994
36. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J: Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler Thromb Vasc Biol 15:2207-2212, 1995
37. Shin WS, Hong Y, Peng H, De Caterina R, Libby P, Liao JK: Nitric oxide attenuates vascular smooth muscle cell activation by interferon-γ. J Biol Chem 271:11317-11324, 1996
38. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NK-KB and cytokine-inducible enhancers. FASEB J 9:899-909, 1995
39. Bing-Shu H, Agranoff AB, Nabel EG, Leung K, Duckett CS, Neish AS, Collins T, Nabel GJ: Differential regulation of vascular cell adhesion molecule-1 gene expression by specific NF-KB subunits in endothelial and epithelial cells. Mol Cell Biol 13:6283-6289, 1993
40. Li H, Cybulsky MI, Gimbrone MA, Libby P: Inducible expression of vascular cell adhesion molecule by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 143:1551-1559, 1993
41. Couffinhal T, Duplaa C, Moreau C, Lamaziere JD, Bonnet J: Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res 74:225-234, 1994
42. Obata H, Biro S, Arima N, Kaieda H, Kihara T, Eto H, Miyata M, Tanaka H: NF-KB is induced in the nuclei of rat aortic smooth muscle cells by stimulation of various growth factors. Biochem Biophys Res Commun 224:27-32, 1996
43. Wolff SP: Diabetes mellitus and free radicals: free radicals, transition metals, and oxidative stress in the etiology of diabetes mellitus and complications. Br Med Bull 49:642-652, 1993
44. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T: Requirement for generation of hydrogen peroxide for platelet-derived growth factor signal transduction. Science 270:296-299, 1995
45. Marumo T, Schini-Kerth VB, Fissthaler B, Busse R: Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-KB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96:2361-2367, 1997
46. Hecker M, Preiss C, Schini-Kerth VB, Busse R: Antioxidants differentially affect nuclear factor KB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett 380:224-228, 1996
47. ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810-17814, 1997